netFormulary NHS
Calderdale and Huddersfield
NHS Foundation Trust
Formulary
 Search
 Formulary Chapter 6: Endocrine system - Full Chapter
06.01.02.03  Expand sub section  Other antidiabetic drugs
Acarbose (Glucobay)
View adult BNF View SPC online View childrens BNF
Formulary  
   
Pioglitazone (Actos)
(Thiazolidinedione)
View adult BNF View SPC online View childrens BNF
Formulary  
   
Repaglinide (Prandin)
View adult BNF View SPC online View childrens BNF
Formulary  
   
06.01.02.03  Expand sub section  Alpha glucosidase inhibitors
06.01.02.03  Expand sub section  DPP4 inhibitors (gliptins)
Alogliptin (Vipidia▼)
View adult BNF View SPC online View childrens BNF
Formulary  
   
Linagliptin (Trajenta▼)
(DPP4 inhibitor)
View adult BNF View SPC online View childrens BNF
Formulary  
   
Sitagliptin (Januvia)
(DPP4 inhibitor)
View adult BNF View SPC online View childrens BNF
Formulary  
   
06.01.02.03  Expand sub section  GLP1 agonists
Liraglutide (Victoza)
(GLP1 agonist)
View adult BNF View SPC online View childrens BNF
First Choice

note  First line DAILY preparation

 
Semaglutide (Ozempic)
View adult BNF View SPC online View childrens BNF
First Choice

note First line WEEKLY preparation

 
Dulaglutide
View adult BNF View SPC online View childrens BNF
Second Choice

note  Second line WEEKLY preparation

 
   
Lixisenatide (Lyxumia▼)
(GLP1 agonist)
View adult BNF View SPC online View childrens BNF
Second Choice

note  Second line DAILY preparation

 
   
06.01.02.03  Expand sub section  Meglitinides to top
06.01.02.03  Expand sub section  SGL2 inhibitors
Ertugliflozin (Steglatro▼)
(SGLT2 inhibitor)
View adult BNF View SPC online View childrens BNF
First Choice
Green
 
Canagliflozin (Invokana▼)
(SGLT2 inhibitor)
View adult BNF View SPC online View childrens BNF
Second Choice
Green
 
Link  NICE TA315: Canagliflozin for type 2 diabetes
Link  NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
   
Dapagliflozin (Forxiga▼)
(SGLT-2 inhibitor)
View adult BNF View SPC online View childrens BNF
Second Choice
Green
 
Link  NICE TA288: Dapagliflozin in combination therapy for treating type 2 diabetes
Link  NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
Link  NICE TA418: Dapagliflozin in triple therapy for treating type 2 diabetes
Link  NICE TA597:Dapagliflozin with insulin for treating type 1 diabetes
   
Empagliflozin (Jardiance▼)
(SGLT-2 inhibitor)
View adult BNF View SPC online View childrens BNF
Second Choice

Updated 25th October 2019 

Revised SPCs: Empagliflozin products (Jardiance, Synjardy, Glyxambi)

SPCs updated to state treatment should be interrupted in patients hospitalised for major surgical procedures/acute serious medical illnesses and monitoring of ketones recommended (blood preferred to urine levels), and treatment restarted when ketones normal and patient.

 
Link  NICE TA336: Empagliflozin for type 2 diabetes
Link  NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
   
06.01.02.03  Expand sub section  Thiazolidinediones
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
Homecare
Homecare

Traffic Light Status Information

Status Description

Red

RED  

Amber

AMBER  

Green

GREEN  

Green SI

GREEN SPECIALIST INITIATION  

netFormulary